New antiarrhythmic agents for atrial fibrillation and atrial flutter

Author： Pecini Redi Elming Hanne Pedersen Ole Dyg Torp-Pedersen Christian

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.2, 2005-05, pp. : 311-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent

Heart Drug, Vol. 1, Iss. 6, 2002-02 ,pp. : 320-331

Karger

Access to resources Recommend Favorite

Antiarrhythmic drugs for atrial fibrillation

By Marinelli Alessandro Capucci Alessandro

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1201-1215

Informa Healthcare

Access to resources Recommend Favorite

Antiarrhythmic drugs in atrial fibrillation: an overview of new agents, their mechanisms of action and potential clinical utility

By Choudhury Anirban Lip Gregory YH

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 7, 2004-07 ,pp. : 841-855

Informa Healthcare

Access to resources Recommend Favorite

Lacosamide: Atrial flutter and atrial fibrillation: case report

Reactions Weekly, Vol. 1, Iss. 1316, 2010-01 ,pp. : 28-29

Adis International

Access to resources Recommend Favorite

Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter

Current Pharmaceutical Design, Vol. 14, Iss. 8, 2008-03 ,pp. : 770-775

Bentham Science Publishers

Access to resources Recommend Favorite